Home > Income Statement > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Revenue

    Back to Income Statement
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹581 Cr₹510 Cr₹472 Cr₹424 Cr₹386 Cr

What is the latest Revenue of LINCOLN PHARMACEUTICALS ?

The latest Revenue ratio of LINCOLN PHARMACEUTICALS is ₹581 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹581 Cr
Mar2023₹510 Cr
Mar2022₹472 Cr
Mar2021₹424 Cr
Mar2020₹386 Cr

How is Revenue of LINCOLN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹581 Cr
13.76
Mar2023 ₹510 Cr
8.09
Mar2022 ₹472 Cr
11.30
Mar2021 ₹424 Cr
9.75
Mar2020 ₹386 Cr -

Compare Revenue of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,141.3 Cr -4.2% -6.4% -8.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,326.0 Cr -2.3% -3.5% 9.2% Stock Analytics
DIVIS LABORATORIES ₹173,562.0 Cr -2.8% 1.3% 42.3% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 3% -2.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,558.0 Cr -3.7% 7.2% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,204.0 Cr -1% -0.5% 13.2% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

-4.2%

-6.4%

-8.1%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses